The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders

Completed · Not applicable

Conditions studied: vonWillebrand Disease, Hemophilia, Platelet Coagulation Disorders

In brief

The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments. This has led to development of this protocol in order to make available tranexamic acid as a potentially effective menorrhagia therapy option in women with an underlying bleeding disorder. We anticipate that Tranexamic Acid may be a beneficial choice for controlling menorrhagia in bleeding disorder patients.

Key facts

Study ID

NCT00697385

Run by

Mary M. Gooley Hemophilia Center

People needed

13

Starts

2003-04-01

Expected to finish

2008-06-01

Last updated by the study team

2008-09-19

Who can join

Age: 8 and older, up to 60. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• all menstruating women regardless of age
• Women with heavy periods as measured by pictorial blood assessment chart
• Women diagnosed with a bleeding disorder

You may not qualify if…

• Acquired defective color vision
• Factor VIII, Factor IX, FactorXI levels >250%
• An inherited thrombophilic defect detected because of a positive family or personal history of thrombosis
• Current use of oral contraceptives

Where it is running

• Mary M. Gooley Hemophilia Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.